First Horizon Advisors’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.6K Sell
1,792
-18
-1% -$368 ﹤0.01% 1166
2025
Q1
$36.2K Sell
1,810
-200
-10% -$4K ﹤0.01% 1075
2024
Q4
$53.6K Sell
2,010
-60
-3% -$1.6K ﹤0.01% 920
2024
Q3
$59K Sell
2,070
-5,783
-74% -$165K ﹤0.01% 913
2024
Q2
$171K Hold
7,853
0.01% 543
2024
Q1
$174K Hold
7,853
0.01% 537
2023
Q4
$169K Sell
7,853
-250
-3% -$5.4K 0.01% 523
2023
Q3
$137K Buy
8,103
+672
+9% +$11.4K 0.01% 551
2023
Q2
$102K Buy
7,431
+442
+6% +$6.06K ﹤0.01% 639
2023
Q1
$159K Buy
6,989
+18
+0.3% +$409 0.01% 523
2022
Q4
$164K Sell
6,971
-257
-4% -$6.05K 0.01% 496
2022
Q3
$188K Buy
7,228
+6,682
+1,224% +$174K 0.01% 450
2022
Q2
$11K Sell
546
-52
-9% -$1.05K ﹤0.01% 1532
2022
Q1
$27K Buy
598
+138
+30% +$6.23K ﹤0.01% 808
2021
Q4
$19K Sell
460
-101
-18% -$4.17K ﹤0.01% 1294
2021
Q3
$37K Buy
561
+179
+47% +$11.8K ﹤0.01% 1028
2021
Q2
$28K Buy
382
+111
+41% +$8.14K ﹤0.01% 986
2021
Q1
$18K Sell
271
-61
-18% -$4.05K ﹤0.01% 1105
2020
Q4
$22K Buy
332
+149
+81% +$9.87K ﹤0.01% 863
2020
Q3
$9K Buy
+183
New +$9K ﹤0.01% 1029